These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 9826102)
21. Neurochemical, neuroautonomic and neuropharmacological acute effects of sibutramine in healthy subjects. Lechin F; van der Dijs B; Hernandez G; Orozco B; Rodriguez S; Baez S Neurotoxicology; 2006 Mar; 27(2):184-91. PubMed ID: 16269176 [TBL] [Abstract][Full Text] [Related]
22. Effects of an oral dose of l-glutamic acid on circulating neurotransmitters: Possible roles of the C1(Ad) and the A5(NA) pontomedullary nuclei. Lechin F; van der Dijs B; Pardey-Maldonado B; Rivera JE; Lechin ME; Baez S J Exp Pharmacol; 2010; 2():47-53. PubMed ID: 27186090 [TBL] [Abstract][Full Text] [Related]
23. Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control. Fanciullacci M; Sicuteri R; Alessandri M; Geppetti P Clin Pharmacol Ther; 1995 Mar; 57(3):349-55. PubMed ID: 7697953 [TBL] [Abstract][Full Text] [Related]
24. Correlation between plasma neurotransmitters and memory loss in pregnancy. Shetty DN; Pathak SS J Reprod Med; 2002 Jun; 47(6):494-6. PubMed ID: 12092020 [TBL] [Abstract][Full Text] [Related]
25. Behavioral studies with anxiolytic drugs. IV. Serotonergic involvement in the effects of buspirone on punished behavior of pigeons. Witkin JM; Mansbach RS; Barrett JE; Bolger GT; Skolnick P; Weissman B J Pharmacol Exp Ther; 1987 Dec; 243(3):970-7. PubMed ID: 2891840 [TBL] [Abstract][Full Text] [Related]
26. Doxepin therapy for postprandial symptomatic hypoglycaemic patients: neurochemical, hormonal and metabolic disturbances. Lechin F; van der Dijs B; Lechin A; Lechin M; Coll-García E; Jara H; Cabrera A; Jiménez V; Gómez F; Tovar D Clin Sci (Lond); 1991 Apr; 80(4):373-84. PubMed ID: 1673882 [TBL] [Abstract][Full Text] [Related]
27. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action. Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425 [TBL] [Abstract][Full Text] [Related]
28. Anxiolytic 5-hydroxytryptamine1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats. Tada K; Kasamo K; Ueda N; Suzuki T; Kojima T; Ishikawa K J Pharmacol Exp Ther; 1999 Feb; 288(2):843-8. PubMed ID: 9918598 [TBL] [Abstract][Full Text] [Related]
29. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential. Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347 [TBL] [Abstract][Full Text] [Related]
30. Effect of sampling site and conditions on plasma levels of noradrenaline, adrenaline and dopamine. Saar N; Jackson R; Bachmann A; Gordon R Prog Biochem Pharmacol; 1980; 17():90-7. PubMed ID: 7208507 [TBL] [Abstract][Full Text] [Related]
31. Characteristics of the anxiolytic effects of buspirone in high- and low-anxious normal humans assessed by frontal midline theta activity. Mizuki Y; Suetsugi M; Ushijima I; Yamada M Methods Find Exp Clin Pharmacol; 1994 May; 16(4):291-300. PubMed ID: 7519702 [TBL] [Abstract][Full Text] [Related]
32. Motor effects of buspirone: Relationship with dopamine and serotonin in the striatum. Shireen E; Haleem DJ J Coll Physicians Surg Pak; 2005 Dec; 15(12):753-6. PubMed ID: 16398963 [TBL] [Abstract][Full Text] [Related]
33. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. Blonski W; Vela MF; Freeman J; Sharma N; Castell DO J Clin Gastroenterol; 2009 Mar; 43(3):253-60. PubMed ID: 18987553 [TBL] [Abstract][Full Text] [Related]
34. Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats. Fuller RW; Perry KW J Pharmacol Exp Ther; 1989 Jan; 248(1):50-6. PubMed ID: 2521515 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of apomorphine-induced conditioned place preference in rats co-injected with buspirone: relationship with serotonin and dopamine in the striatum. Haleem DJ; Ikram H; Haleem MA Brain Res; 2014 Oct; 1586():73-82. PubMed ID: 25160128 [TBL] [Abstract][Full Text] [Related]
36. Tolerance in the anxiolytic profile following repeated administration of diazepam but not buspirone is associated with a decrease in the responsiveness of postsynaptic 5-HT-1A receptors. Khan A; Haleem DJ Acta Biol Hung; 2007 Dec; 58(4):345-57. PubMed ID: 18277461 [TBL] [Abstract][Full Text] [Related]
37. Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety. Crespi F J Neurosci Methods; 2009 May; 180(1):97-105. PubMed ID: 19427535 [TBL] [Abstract][Full Text] [Related]
38. Buspirone: review of its pharmacology and current perspectives on its mechanism of action. Eison AS; Temple DL Am J Med; 1986 Mar; 80(3B):1-9. PubMed ID: 2870639 [TBL] [Abstract][Full Text] [Related]
39. Quantifying the 5-HT1A agonist action of buspirone in man. Bridge MW; Marvin G; Thompson CE; Sharma A; Jones DA; Kendall MJ Psychopharmacology (Berl); 2001 Nov; 158(3):224-9. PubMed ID: 11713611 [TBL] [Abstract][Full Text] [Related]
40. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress. Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]